| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.58B | 29.32B | 26.18B | 23.52B | 21.40B | 18.79B |
| Gross Profit | 9.01B | 8.27B | 7.27B | 6.38B | 5.69B | 4.62B |
| EBITDA | 4.11B | 3.56B | 3.08B | 2.64B | 2.16B | 1.20B |
| Net Income | 2.79B | 2.44B | 2.09B | 1.77B | 1.33B | 578.88M |
Balance Sheet | ||||||
| Total Assets | 22.48B | 22.91B | 20.02B | 17.41B | 15.54B | 12.86B |
| Cash, Cash Equivalents and Short-Term Investments | 9.07B | 7.21B | 7.97B | 7.21B | 6.46B | 4.85B |
| Total Debt | 57.63M | 232.99M | 202.16M | 40.36M | 62.62M | 432.08M |
| Total Liabilities | 6.90B | 8.08B | 7.31B | 6.60B | 6.35B | 6.01B |
| Stockholders Equity | 15.51B | 14.76B | 12.66B | 10.77B | 9.16B | 6.82B |
Cash Flow | ||||||
| Free Cash Flow | 3.40B | 1.64B | 1.39B | 976.24M | 1.08B | 2.03B |
| Operating Cash Flow | 3.45B | 1.76B | 1.89B | 1.07B | 1.16B | 2.13B |
| Investing Cash Flow | -1.13B | -1.98B | -761.48M | -541.66M | -80.91M | 87.03M |
| Financing Cash Flow | -1.04B | -599.35M | -424.08M | -280.82M | 486.86M | -1.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥47.73B | 12.84 | 8.02% | 2.73% | 8.26% | 9.09% | |
77 Outperform | ¥28.82B | 12.67 | ― | 2.93% | 11.53% | 23.23% | |
77 Outperform | ¥73.78B | 21.08 | 31.71% | 1.68% | 16.12% | 46.57% | |
74 Outperform | ¥63.98B | 10.69 | ― | 2.41% | 13.05% | 4.42% | |
72 Outperform | ¥50.72B | 23.84 | ― | 1.50% | 13.48% | 35.63% | |
68 Neutral | ¥32.79B | 20.63 | ― | 4.58% | 4.58% | -15.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |